Latest news with #Gerresheimer
Bloomberg
4 days ago
- Business
- Bloomberg
Warburg Said in Talks to Team Up With KPS on Gerresheimer
Warburg Pincus is in discussions with KPS Capital Partners about teaming up on an offer for Gerresheimer AG, the German maker of packaging for drugs and cosmetics, according to people familiar with the matter. The private equity firms are considering a bid in the €70s for each Gerresheimer share, said the people, who asked not to be identified as the information is private. KPS is mainly interested in the company's moulded glass operations, the people said.
Yahoo
4 days ago
- Business
- Yahoo
What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?
While Gerresheimer AG (ETR:GXI) might not have the largest market cap around , it led the XTRA gainers with a relatively large price hike in the past couple of weeks. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. But what if there is still an opportunity to buy? Today we will analyse the most recent data on Gerresheimer's outlook and valuation to see if the opportunity still exists. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. According to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. We've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 26.77x is currently trading slightly below its industry peers' ratio of 32.29x, which means if you buy Gerresheimer today, you'd be paying a reasonable price for it. And if you believe that Gerresheimer should be trading at this level in the long run, then there's not much of an upside to gain over and above other industry peers. Furthermore, it seems like Gerresheimer's share price is quite stable, which means there may be less chances to buy low in the future now that it's priced similarly to industry peers. This is because the stock is less volatile than the wider market given its low beta. See our latest analysis for Gerresheimer Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to more than double over the next couple of years, the future seems bright for Gerresheimer. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. Are you a shareholder? It seems like the market has already priced in GXI's positive outlook, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the track record of its management team. Have these factors changed since the last time you looked at GXI? Will you have enough conviction to buy should the price fluctuate below the industry PE ratio? Are you a potential investor? If you've been keeping tabs on GXI, now may not be the most advantageous time to buy, given it is trading around industry price multiples. However, the optimistic forecast is encouraging for GXI, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. To help with this, we've discovered 4 warning signs (2 are potentially serious!) that you ought to be aware of before buying any shares in Gerresheimer. If you are no longer interested in Gerresheimer, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
11-05-2025
- Business
- Yahoo
Gerresheimer AG (ETR:GXI) is largely controlled by institutional shareholders who own 77% of the company
Institutions' substantial holdings in Gerresheimer implies that they have significant influence over the company's share price 52% of the business is held by the top 13 shareholders Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. A look at the shareholders of Gerresheimer AG (ETR:GXI) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 77% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait. Let's take a closer look to see what the different types of shareholders can tell us about Gerresheimer. View our latest analysis for Gerresheimer Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing. We can see that Gerresheimer does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Gerresheimer, (below). Of course, keep in mind that there are other factors to consider, too. Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. Hedge funds don't have many shares in Gerresheimer. Our data shows that Goldman Sachs Asset Management, L.P. is the largest shareholder with 8.9% of shares outstanding. Asset Value Investors Limited is the second largest shareholder owning 6.2% of common stock, and BlackRock, Inc. holds about 4.9% of the company stock. A closer look at our ownership figures suggests that the top 13 shareholders have a combined ownership of 52% implying that no single shareholder has a majority. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions. We can see that insiders own shares in Gerresheimer AG. This is a big company, so it is good to see this level of alignment. Insiders own €90m worth of shares (at current prices). If you would like to explore the question of insider alignment, you can click here to see if insiders have been buying or selling. The general public-- including retail investors -- own 16% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders. I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Like risks, for instance. Every company has them, and we've spotted 4 warning signs for Gerresheimer (of which 2 shouldn't be ignored!) you should know about. Ultimately the future is most important. You can access this free report on analyst forecasts for the company. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
11-04-2025
- Business
- Reuters
Gerresheimer's first-quarter results hit by low demand in moulded glass
April 11 (Reuters) - German packaging and medical equipment maker Gerresheimer ( opens new tab reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe revenues into later quarters. Its adjusted operating earnings before depreciation and amortisation (EBITDA) were 91.4 million euros ($103.29 million) including recently acquired Bormioli Pharma. They were down 9.3% on an organic basis compared to the same period last year.
Yahoo
04-04-2025
- Business
- Yahoo
European shares drop at the end of brutal week after Trump's tariff blow
(Reuters) - European shares dipped on Friday, heading for a steep weekly loss, as investors grappled with prospects of a global recession after U.S. President Donald Trump announced sweeping tariffs on trading partners. The pan-European STOXX index fell 0.9% at 0710 GMT, taking its losses for the week to 4.4%, the sharpest weekly decline since June 2022. Europe was hit with a 20% U.S. import tariff rate, prompting traders to increase their bets on interest rate cuts from the European Central Bank to shore up economic growth. European banks, sensitive to economic outlook, racked up the most losses among sectors, shedding 3.8%. A crucial March U.S. jobs report at 1230 GMT will be scrutinized to gauge the health of the world's biggest economy before the latest round of tariffs ignited recession fears. Data on Friday showed German industrial orders stagnated in February and the January data were upwardly revised, showing that Germany's industrial sector could have bottomed out but the recovery may be slow. Among stocks, Gerresheimer fell 6% after a report said KKR has abandoned a private equity consortium discussing a takeover of the German speciality packaging maker. Sign in to access your portfolio
